Nilotinib exerts proatherogenic and growth-inhibitory effects on endothelial cells: a potential mechanism underlying drug-related vasculopathy in Ph plus CML
Emir Hadzijusufovic(University of Veterinary Medicine Vienna), Peter Valent(Medical University of Vienna), Johann Wojta(Medical University of Vienna), Gregor Hoermann(University of Freiburg), Dominik Wolf(Universität Innsbruck), Susanne Herndlhofer(Assistance Publique – Hôpitaux de Paris), Willfried Schgoer, Markus Theurl(Innsbruck Medical University), Sabine Cerny‐Reiterer(Medical University of Vienna), K. Huber(Austrian Academy of Sciences), Gregor Eisenwort(Ludwig Boltzmann Institute for Cardiovascular Research), Karin Albrecht-Schgoer(Innsbruck Medical University), Giulio Superti‐Furga(Austrian Academy of Sciences), Wolfgang R. Sperr(Medical University of Vienna), Bernd Jilma(Medical University of Vienna), Irina Sadovnik(Medical University of Vienna), Rudolf Kirchmair(Innsbruck Medical University), Florian Grebien(University of Veterinary Medicine Vienna), Viviane Ghanim(Medical University of Vienna), Christoph Kaun(University of Vienna), Uwe Rix(University of South Florida)
Unknown
January 1, 2014
Cited by 0
Related Papers
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848
Polar secretion of endothelin-1 by cultured endothelial cells.
|Journal of Biological Chemistry|1992|645
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589